Insufficient scRNA-seq data for expression of NHLRC1 at single-cell level.
Insufficient scRNA-seq data for expression of NHLRC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 98% | 131.97 | 452 / 459 | 97% | 9.79 | 1079 / 1118 |
liver | 100% | 200.54 | 226 / 226 | 95% | 8.72 | 384 / 406 |
prostate | 94% | 74.41 | 231 / 245 | 97% | 6.79 | 488 / 502 |
thymus | 94% | 106.88 | 611 / 653 | 96% | 5.57 | 578 / 605 |
bladder | 100% | 97.00 | 21 / 21 | 86% | 6.18 | 432 / 504 |
pancreas | 94% | 79.61 | 308 / 328 | 87% | 4.09 | 154 / 178 |
adrenal gland | 95% | 153.59 | 246 / 258 | 85% | 5.13 | 195 / 230 |
skin | 100% | 291.01 | 1807 / 1809 | 79% | 10.23 | 375 / 472 |
esophagus | 91% | 81.55 | 1308 / 1445 | 88% | 6.99 | 161 / 183 |
uterus | 86% | 72.31 | 146 / 170 | 91% | 8.57 | 416 / 459 |
intestine | 95% | 99.72 | 918 / 966 | 78% | 5.40 | 413 / 527 |
brain | 99% | 197.66 | 2604 / 2642 | 72% | 3.47 | 509 / 705 |
ovary | 73% | 44.78 | 131 / 180 | 98% | 12.37 | 420 / 430 |
stomach | 88% | 61.79 | 317 / 359 | 75% | 5.12 | 215 / 286 |
lung | 68% | 70.20 | 395 / 578 | 90% | 8.14 | 1043 / 1155 |
kidney | 80% | 53.26 | 71 / 89 | 66% | 2.56 | 595 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.04 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 8.51 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 98% | 13.10 | 78 / 80 |
spleen | 97% | 92.18 | 234 / 241 | 0% | 0 | 0 / 0 |
adipose | 95% | 103.87 | 1147 / 1204 | 0% | 0 | 0 / 0 |
muscle | 95% | 147.23 | 763 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 91% | 88.46 | 1219 / 1335 | 0% | 0 | 0 / 0 |
heart | 83% | 70.32 | 711 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 1.30 | 14 / 29 |
peripheral blood | 38% | 20.66 | 356 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0001932 | Biological process | regulation of protein phosphorylation |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0006914 | Biological process | autophagy |
GO_1903076 | Biological process | regulation of protein localization to plasma membrane |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0017148 | Biological process | negative regulation of translation |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0030371 | Molecular function | translation repressor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NHLRC1 |
Protein name | E3 ubiquitin-protein ligase NHLRC1 (EC 2.3.2.27) (Malin) (NHL repeat-containing protein 1) (RING-type E3 ubiquitin transferase NHLRC1) |
Synonyms | EPM2B |
Description | FUNCTION: E3 ubiquitin-protein ligase. Together with the phosphatase EPM2A/laforin, appears to be involved in the clearance of toxic polyglucosan and protein aggregates via multiple pathways. In complex with EPM2A/laforin and HSP70, suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system (UPS). Ubiquitinates the glycogen-targeting protein phosphatase subunits PPP1R3C/PTG and PPP1R3D in a laforin-dependent manner and targets them for proteasome-dependent degradation, thus decreasing glycogen accumulation. Polyubiquitinates EPM2A/laforin and ubiquitinates AGL and targets them for proteasome-dependent degradation. Also promotes proteasome-independent protein degradation through the macroautophagy pathway. . |
Accessions | Q6VVB1 ENST00000340650.6 |